These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4447892)

  • 1. Serum calcium, phosphate and alkaline phosphatase and morphometric bone examinations in 30 patients with renal insufficiency.
    Duursma SA; Visser WJ; Mees EJ; Njio L
    Calcif Tissue Res; 1974; 16(2):129-38. PubMed ID: 4447892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G; Schaefer K; Schulz A; Delling G
    Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
    Ahmed KY; Varghese Z; Meinhard EA; Baillod RA; Skinner RK; Wills MR; Moorhead JF
    Adv Exp Med Biol; 1977; 81():581-90. PubMed ID: 899942
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
    Malluche HH; Faugere MC; Fanti P; Price PA
    Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha-Hydroxycholecalciferol in renal osteodystrophy.
    Pierides AM; Ellis HA; Ward MK; Simpson W; Kerr DN
    Calcif Tissue Res; 1977 May; 22 Suppl():105-11. PubMed ID: 912511
    [No Abstract]   [Full Text] [Related]  

  • 6. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodialysis bone disease: correlation between clinical, histologic, and other findings.
    Alvarez-Ude F; Feest TG; Ward MK; Pierides AM; Ellis HA; Peart M; Simpson W; Weightman D; Kerr DN
    Kidney Int; 1978 Jul; 14(1):68-73. PubMed ID: 682426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of biochemical with radiological findings in renal osteodystrophy.
    Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Wills MR
    Ann Clin Biochem; 1975 May; 12(3):126-31. PubMed ID: 15637920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal osteodystrophy in non-dialysed patients with chronic renal failure.
    Andresen J; Nielsen HE
    Acta Radiol Diagn (Stockh); 1980; 21(6):803-6. PubMed ID: 7234496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
    Goulding A; McChesney R; Irvine RO; Dixon SR
    N Z Med J; 1974 Dec; 80(530):540-4. PubMed ID: 4615274
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical problems of renal osteopathy in patients on hemofiltration.
    Schulz W; Baier E; Hümpfner A; Delling G
    Contrib Nephrol; 1982; 32():86-91. PubMed ID: 7128166
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
    Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum calcium, phosphorus and alkaline phosphatase as indicators in the therapy of renal osteodystrophy].
    Labos I; Kovacević M
    Med Arh; 1988; 42(4):181-5. PubMed ID: 3270761
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.
    Winney RJ; Bone JM; Anderson TJ; Robson JS
    Calcif Tissue Res; 1977 May; 22 Suppl():94-100. PubMed ID: 912593
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma hydroxyproline in renal osteodystrophy.
    Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
    [No Abstract]   [Full Text] [Related]  

  • 17. Total body calcium and long-term calcium balance in chronic renal disease.
    Denney JD; Sherrard DJ; Nelp WB; Chesnut CH; Baylink DJ
    J Lab Clin Med; 1973 Aug; 82(2):226-40. PubMed ID: 4721378
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum bone gla-protein compared to bone histomorphometry in hemodialyzed patients.
    Charhon SA; Delmas PD; Malaval L; Chavassieux PM; Chapuy MC; Meunier PJ
    Adv Exp Med Biol; 1986; 208():291-6. PubMed ID: 3494387
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.
    Junor BJ; Catto GR; Macleod M
    Calcif Tissue Res; 1977 May; 22 Suppl():112-6. PubMed ID: 912512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.